0 Nanoplasmonics used for monitoring biofilm formation
Researchers from the Okinawa Institute of Science and Technology have developed a method to study biofilm formation, and how it is affected by drugs, with high efficacy.
Browsing: Bacterial > E. Coli
0 Novel models for enteric infections – an interview with the Faherty Lab
In line with our July focus around enteric infections, we recently spoke to Christina Faherty and Research Fellow from her lab, Alejandro Llanos-Chea, about the lab’s research on Shigella, Salmonella and E. coli and novel models for these in vitro.
0 A peek behind the paper – Jeffrey Henderson on iron in uropathogenic E. coli
In this interview, take a look behind the scenes of a recent Future Microbiology paper on the role of transition metal control in E. coli virulence with author, Jeffrey Henderson.
0 Infographic: The burden of foodborne diseases
In this infographic we take a look at the estimated burden of some key foodborne diseases in terms of both cases and mortality.
1 Could bacterial immunotherapy replace antibiotics against Gram-negative bacteria?
Small-molecule compounds designed to tag the cell surface of Gram-negative bacteria and trigger an immunological response have shown promise.
0 ASM Microbe: Genetic analysis used to show transfer of carbapenem resistance
Whole-genome sequencing has been used to demonstrate that carbapenem resistance can be transferred among unrelated bacteria species in a healthcare setting.
0 ASM Microbe: High prevalence of colistin-resistant E. coli discovered in rural Vietnam
Researchers have discovered a high prevalence of colistin-resistant E. coli in the Vietnamese town of Nguyen Xa, according to research presented at ASM Microbe.
0 ASM Microbe: Understanding antibiotic resistance in waterways
In research presented at ASM Microbe a team have delved into the dynamics of E. coli in urban streams in the USA, indicating possible antibiotic resistance activity.
0 ECCMID18: Researchers identify the role of novel mutations fosfomycin resistance
Research presented at ECCMID outlines the identification and role of novel chromosomal mutations in the development of resistance of Escherichia coli to the broad-spectrum antibiotic fosfomycin.
1 ECCMID18: Piperacillin-tazobactam should be avoided for bloodstream infections caused by ceftriaxone-resistant E. coli and K. pneumoniae
The results of the MERINO trial have been reported at ECCMID, revealing the combination treatment piperacillin-tazobactam is significantly less effective than meropenem in treating some bloodstream infections.
